top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cardio-Nephrology : Confluence of the Heart and Kidney in Clinical Practice / / edited by Janani Rangaswami, Edgar V. Lerma, Claudio Ronco
Cardio-Nephrology : Confluence of the Heart and Kidney in Clinical Practice / / edited by Janani Rangaswami, Edgar V. Lerma, Claudio Ronco
Edizione [1st ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Descrizione fisica 1 online resource (443 pages) : illustrations (some color)
Disciplina 616.12
Soggetto topico Nephrology
Cardiology
Critical care medicine
Intensive / Critical Care Medicine
ISBN 3-319-56042-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto PART I: CARDIOVASCULAR DISEASE SPECTRUM IN CHRONIC KIDNEY DISEASE -- Chapter 1 Endothelial Dysfunction and Nitric Oxide: Albuminuria as a Central Marker -- Chapter 2 Vascular and Valvular Calcification in Chronic Kidney Disease: Pathogenesis and Clinical Outcomes -- Chapter 3 Sudden Cardiac Death in CKD and ESKD: Risk Factors, Mechanisms, and Therapeutic Strategies -- Chapter 4 Coronary Artery Disease in CKD: Traditional and Nontraditional Risk Factors, Diagnosis and Management -- Chapter 5 CKD Associated Cardiomyopathy: Molecular Mechanisms, Imaging Modalities, Disease Evolution and Interventions -- PART II: CHRONIC KIDNEY DISEASE AND CAD: TWO SIDES OF THE SAME COIN -- Chapter 6 CKD as CAD Equivalent: Inflammatory Milieu and Vascular Oxidative Stress -- Chapter 7 Phosphorus and Mortality: Do we have the Panacea? -- Chapter 8 Inhibition of the Renin Angiotensin System: How far have we come? -- Chapter 9 Vitamin D and its Role in CKD and CAD: A Novel Therapeutic Target -- Chapter 10 Association of Catalytic (Labile) Iron with Cardiovascular Morbidity and Mortality -- Chapter 11 Erythropoietin and its Cardiovascular Effects -- PART III: CARDIO-RENAL SYNDROME -- Chapter 12 Pathophysiology of the Cardio-Renal Syndromes Types 1–5: Updates from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) -- Chapter 13 Hemodynamic Cross Talk in Cardiorenal Syndrome: Era of Biomarkers -- Chapter 14 Kidney Attack: Is NGAL Set to Take the Stage with Troponins? -- Chapter 15 Ultrafiltration Therapy in Decompensated Heart Failure -- Chapter 16 Bioimpedance Vectorial Analyses in Cardio Renal Syndrome -- Chapter 17 Novel Therapies for Acute Decompensated Heart Failure -- Chapter 18 Kidney Injury in Patients with Ventricular Assist Devices -- Chapter 19 Palliation with Dual Burden of Heart and Kidney Failure: An Underutilized Strategy -- PART IV: CARDIAC EVALUATION OF THE RENAL TRANSPLANT CANDIDATE -- Chapter 20 Screening Strategies for Coronary Artery Disease (CAD) in Candidates for Kidney Transplants -- Chapter 21 Cardiac Pre-Operative Evaluation as an Opportunity to Optimize Risk Factors in Kidney Transplant Candidates -- Chapter 22 Revascularization in Patients on the Renal Transplant List: When and What is Appropriate? -- Chapter 23 Pulmonary Hypertension in the Potential Kidney Transplant Recipient -- Chapter 24 Cardiac Surveillance whilst Listed for Renal Transplantation -- Chapter 25 Post Kidney Transplant Modification of Cardiovascular Risk -- Ch. 26 Cardiomyopathy in the Potential Kidney Transplant Candidate -- PART V: ANTICOAGULATION AND ANTIPLATELET THERAPY IN CKD -- Chapter 27 Anticoagulation in Patients with Atrial Fibrillation and Chronic Kidney Disease -- Chapter 28 Anticoagulation-Related Nephropathy: Tip of the Iceberg -- Chapter 29 Impact of Antiplatelet Therapy and Platelet Reactivity Testing on Cardiovascular Outcomes in Patients with Chronic Kidney Disease -- PART VI: INTERVENTIONAL STRATEGIES IN CARDIOVASCULAR DISEASE IN CKD -- Chapter 30 Revascularization Strategies in Chronic Kidney Disease: Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft Surgery -- Chapter 31 Revascularization Strategies in CKD: Anti-Platelet Therapy, Stent Type, Timing, and Complications of PCI -- Chapter 32 Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies -- Chapter 33 Contrast Induced Nephropathy -- Chapter 34 Acute Kidney Injury after Cardiac Surgery -- PART VII: THE CARDIORENOMETABOLIC SPECTRUM -- Chapter 35 Dyslipidemias in CKD and ESKD: Outcomes and Management -- Chapter 36 The Cardiac Impact of Atherosclerotic Renovascular Disease (ARVD) -- Chapter 37 Preeclampsia: A Mirror into Future Cardiovascular and Renal Health -- Chapter 38 Obstructive Sleep Apnea: A Unifying Link between Cardiovascular and Renal Disease -- PART VIII: DILEMMAS IN HYPERTENSION -- Chapter 39 Chronic Kidney Disease and BP Goals -- Chapter 40 Renal Artery Stenosis: Diagnosis and Management -- Chapter 41 Renal Denervation: Current Opinions and Practice.
Record Nr. UNINA-9910254489903321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Kidney Disease in the Cardiac Catheterization Laboratory : A Practical Approach / / edited by Janani Rangaswami, Edgar V. Lerma, Peter A. McCullough
Kidney Disease in the Cardiac Catheterization Laboratory : A Practical Approach / / edited by Janani Rangaswami, Edgar V. Lerma, Peter A. McCullough
Edizione [1st ed. 2020.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020
Descrizione fisica 1 online resource (XX, 473 p. 59 illus., 40 illus. in color.)
Disciplina 616.61
Soggetto topico Nephrology
Cardiology
Malalties del ronyó
Cateterisme cardíac
Soggetto genere / forma Llibres electrònics
ISBN 3-030-45414-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical Outcomes -- Noninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future Directions -- Peripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional Strategies -- Cardiovascular impact of Atherosclerotic Renovascular Disease -- Platelet Function testing and antiplatelet agent choice in CKD -- Choice of stents and clinical outcomes in patients with CKD -- Revascularization strategies in CKD: PCI vs CABG -- Approach to revascularization in the potential kidney transplant recipient -- Nephrology consultative approach and risk stratification prior to revascularization in CKD -- Contrast Induced AKI: Epidemiology, risk stratification and prognosis -- Contrast induced AKI: Pathophysiological Mechanisms -- Prevention of Contrast Induced AKI: Summary of volume optimization strategies -- Prevention of Contrast induced AKI: Contrast medium selection, adjuvant strategies and best clinical practices -- Intra procedural and operator strategies for reduction of contrast induced AKI -- Effect of Percutaneous Ventricular Assist Devices on Renal Function -- Renal athero-embolic disease: An underdiagnosed entity -- Acute kidney injury with trans catheter aortic valve replacement -- Impact of kidney disease in catheter based mitral valve interventions -- Acute kidney injury with peripheral vascular interventions -- Renal Artery Stenosis: State of the Art in Diagnosis and Management -- Renal Denervation: Physiology, scope and current evidence -- Economic impact of AKI and CKD in cardiac interventions -- Biomarkers in early risk stratification and management of post catheterization AKI -- Utilization of the cardio nephrology collaborative in the era of value based medicine.
Record Nr. UNINA-9910416134903321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui